Clinical Trial

D-Cycloserine for Serine Palmitoyltransferase Inhibition

Completed Phase 4
View on ClinicalTrials.gov →
Summary
The overarching objective of this study is to mitigate the neurological decline associated with SPTSSA related Complex Hereditary Spastic Paraplegia
Trial Details
NCT Number NCT07542548
Lead Sponsor Massachusetts General Hospital
Collaborators: Uniformed Services University of the Health Sciences, National Institute of General Medical Sciences (NIGMS)
Conditions Hereditary Spastic Paraplegia
Enrollment 1 participants
Start Date 2024-07-10
Primary Completion 2026-03-17 (estimated)
Study Completion 2026-03-17 (estimated)
Updated on ClinicalTrials.gov 2026-04-21